Literature DB >> 3191480

Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.

D Zajchowski1, V Band, N Pauzie, A Tager, M Stampfer, R Sager.   

Abstract

The expression of genes which may be involved in the regulation of human mammary epithelial cell growth [transforming growth factors alpha and beta] and tumorigenesis [c-myc, erbB2, epidermal growth factor receptor (EGFR), Ha-ras, pS2] has been compared in similarly cultured normal cell strains and tumor cell lines. We have found that the normal breast cells produce high levels of EGFR mRNA, which are translated into nearly 10(5) low affinity epidermal growth factor-binding molecules/cell. In the estrogen receptor-negative lines examined, the EGFR gene was expressed at levels comparable to those in the normal cells. In contrast, EGFR and transforming growth factor alpha mRNAs were reduced in estrogen receptor-positive tumor lines compared to estrogen receptor-negative lines and normal cells. Steady state mRNA levels for transforming growth factor beta, erbB2, c-myc, and Ha-ras in the normal cells were greater than or comparable to those in all of the breast tumor lines. Furthermore, in the absence of gene amplification, only one of the genes examined (i.e., pS2) was overexpressed in a subset of the tumor cells compared to their normal counterparts. Several reports by other investigators have described overexpression of some of these genes in breast biopsies and in tumor lines in studies lacking normal controls. Thus, our results, in which the same genes were not overexpressed compared to normal cells unless amplified, underscore the importance of including appropriate normal controls in studies aimed at defining aberrant patterns of gene expression in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191480

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Routine culturing of normal, dysplastic and malignant human mammary epithelial cells from small tissue samples.

Authors:  J T Emerman; D A Wilkinson
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

2.  Detection of estradiol-induced messenger RNA (pS2) in uninvolved breast tissue from mastectomies for breast cancer.

Authors:  E Hähnel; R Joyce; G Sterrett; J Harvey; R Hähnel
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

Review 3.  Vaccine strategies for glioblastoma: progress and future directions.

Authors:  Christopher Jackson; Jacob Ruzevick; Henry Brem; Michael Lim
Journal:  Immunotherapy       Date:  2013-02       Impact factor: 4.196

4.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

Authors:  V Band; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 5.  The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.

Authors:  C L Arteaga; T C Dugger; S D Hurd
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Down-regulation of laminin-5 in breast carcinoma cells.

Authors:  K J Martin; C P Kwan; K Nagasaki; X Zhang; M J O'Hare; C M Kaelin; R E Burgeson; A B Pardee; R Sager
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

7.  Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging.

Authors:  Lily Yang; Hui Mao; Y Andrew Wang; Zehong Cao; Xianghong Peng; Xiaoxia Wang; Hongwei Duan; Chunchun Ni; Qingan Yuan; Gregory Adams; Mark Q Smith; William C Wood; Xiaohu Gao; Shuming Nie
Journal:  Small       Date:  2009-02       Impact factor: 13.281

8.  Differential expression of human tissue factor in normal mammary epithelial cells and in carcinomas.

Authors:  Z Chen; R Sager
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

9.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Authors:  C L Arteaga; S D Hurd; A R Winnier; M D Johnson; B M Fendly; J T Forbes
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

10.  Redundant cyclin overexpression and gene amplification in breast cancer cells.

Authors:  K Keyomarsi; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.